Events

Next events

There are no upcoming events.

Past events

Monday Muscle Seminar M&Ms: Ryan Corces

Date: 12 June 2023
Time: 16 h 00 min - 17 h 00 min
Location: Visioconference
Monday Muscle Seminar - M&M's
Ryan Corces
Ryan Corces
Zoom link => https://us02web.zoom.us/j/81481320295

More information on the Corces Lab

Monday Muscle Seminar M&Ms: Michael Snyder

Date: 22 May 2023
Time: 16 h 00 min - 17 h 00 min
Location: Visioconférence
Monday Muscle Seminar - M&M's
Michael Snyder
Zoom link => https://us02web.zoom.us/j/81834911510

Transforming Healthcare Using Deep Data and Wearables

Michael Snyder

Stanford Medicine – Stanford University
Chair, Dept. of Genetics (2009 – Present)
Director, Center for Genomics and Personalized Medicine (2009 – Present)

Michael Snyder Biosktech

Monday Muscle Seminar M&Ms: Dame Pamela Shaw

Date: 17 April 2023
Time: 12 h 00 min - 13 h 00 min
Location: Visioconference
Monday Muscle Seminar - M&M's
Pamela Shaw
Pamela Shaw
Zoom link => https://us02web.zoom.us/j/86114044204

Motor neuron disease: a neurodegenerative disorder poised for successful therapy development

Professor Dame Pamela Shaw

DBE MBBS MD FRCP FMedSci FAAN FANA  FAAAS

Professor of Neurology,
Honorary Consultant Neurologist, Sheffield Teaching Hospitals NHS Foundation Trust,
Director of the Sheffield Institute for Translational Neuroscience (SITraN),
Director NIHR Sheffield Biomedical Research Centre,
Director of the cross-faculty Neuroscience Research Institute University of Sheffield

 

 

Monday Muscle Seminar M&Ms: Eric Wang

Date: 13 March 2023
Time: 12 h 00 min - 13 h 00 min
Location: Visioconference
Monday Muscle Seminar - M&M's
Eric Wang
Eric Wang
Zoom link => https://us02web.zoom.us/j/85270412441

Repeat Expansions Instigate Supply Chain Issues in Nucleus and Cytoplasm

Eric Wang

University of Florida, Department of Molecular Genetics & Microbiology

 

 

More information on Eric Wang laboratory

Eric T. Wang – Principal Investigator
Eric received his BA in Biochemistry at Harvard College and PhD from the Harvard-MIT Division of Health Sciences & Technology. Following receipt of an NIH Early Independence Award, he started his lab as a Koch Institute Fellow, and subsequently moved to the University of Florida as an Assistant Professor. His interests lie at the intersection of genomics and cell biology, with a focus on better understanding disease pathogenesis underlying repeat expansion diseases. A family connection led him to focus on myotonic dystrophy, a multi-systemic disease affecting muscle, heart, and brain. He has worked with the Myotonic Dystrophy Foundation, the Muscular Dystrophy Association, and Promise to Kate to raise awareness and funding for research. He co-founded Strength, Science and Stories of Inspiration to support the research of young investigators. He also interacts extensively with drug companies to develop meaningful treatment options for people living with severe neurological diseases.

Monday Muscle Seminar M&Ms: Shenhav Cohen

Date: 28 November 2022
Time: 12 h 00 min - 13 h 00 min
Location: Visioconférence
Monday Muscle Seminar - M&M's
Shenhav Cohen
Shenhav Cohen
Zoom link => https://us02web.zoom.us/j/81162361431

Desmin intermediate filament loss promotes muscle wasting during aging or disease

Shenhav Cohen

Russell Berrie Institute for Nanotechnology

Shenhav Cohen Lab: Deciphering the molecular mechanisms that regulate muscle size

Monday Muscle Seminar M&Ms: Brian Glancy

Date: 21 November 2022
Time: 14 h 00 min - 15 h 00 min
Location: Visioconférence
Monday Muscle Seminar - M&M's
Brian Glancy
Brian Glancy
Zoom link => https://us02web.zoom.us/j/86864982792

Sustaining Power: Building Energy Networks in Striated Muscle

Brian Glancy

Earl Stadtman Investigator
NHLBI (NIH National Heart, Lung, and Blood Institute)  and NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases)

More information on Brian Glancy Lab

Monday Muscle Seminar M&Ms: Pascale Bomont

Date: 17 October 2022
Time: 12 h 00 min
Location: Visioconference
Monday Muscle Seminar - M&M's
Pascale Bomont
Zoom link => https://us02web.zoom.us/j/85792428574

Intermediate filaments: from mechanisms in giant axonal neuropathy to therapeutic perspectives for IF-pathies

Pascale Bomont, PhD

ERC group leader, INSERM Research Director
NeuroMyoGene Institute, Lyon, France

 

Studying a rare neurodegenerative disease called giant axonal neuropathy (GAN), Pr Bomont will present the discovery of the gigaxonin-E3 ligase as a pivotal regulator of Intermediate Filament homeostasis, autophagy activation and motor neuron specification. Using the complementarity of various biological systems in human, mouse and zebrafish, the laboratory investigates the roles of these key cellular pathways in neurodegeneration, and is currently developing therapeutic approaches for GAN, that can be beneficial to other IF-pathies.

Pascale Bomont is a Research director at Inserm, University of Lyon1

She received her PhD in Human Genetics in 2002 (IGBMC, Strasbourg, France). Performing linkage and bioinformatics analysis on the Human Genome, she identified the genetic locus and mutated genes for several neuropathies.  Focusing on Gigaxonin, a novel E3-ubiquitin ligase adaptor she found mutated in Giant Axonal Neuropathy (GAN), she conducted a postdoctoral training in Cell Biology (LICR, San Diego, USA) to investigate the broad cytoskeleton (Intermediate Filament) alteration in the pathology.  Moving back to France, she was recruited at INSERM in 2007 (as assistant Professor), and was awarded by the ATIP-Avenir prize in 2011 to run a multidisciplinary research program on GAN, at Montpellier University (Associate Professor in 2012). She developed tools and biological systems in patients, mouse and zebrafish to generate a differential diagnosis test between GAN and CMTs, and to unravel the key roles of the Gigaxonin-E3 ligase in controlling cytoskeleton architecture, autophagy machinery and neuromuscular integrity.

She is now full Professor at University Lyon1, and runs an ERC-program at the NeuroMyogene institute on neurofilament biology.

Monday Muscle Seminar M&Ms: Carol Walton and René Bigirimana

Date: 19 September 2022
Time: 12 h 00 min - 13 h 00 min
Location: Visioconference
Monday Muscle Seminar - M&M's
Argenx
Zoom link => https://us02web.zoom.us/j/87417667754 

Generation of novel therapeutics for neuromuscular diseases through collaboration with disease and target biology academic experts and argenx antibody expertise

Carol Walton and René Bigirimana

Carol Walton, Director of Business Development at argenx and René Bigirimana, Scenior scientist at argenx

 

Short Summary

Argenx strives to combine its technical antibody expertise with external expertise on biological targets through collaborations. Within our Immunology Innovation Program (IIP), we aim to generate novel therapeutic approaches for high unmet need peripheral neuromuscular indication by collaborating with external scientific and academic experts to gain novel insights in disease and target biology.  argenx will provide an Introduction to its Immunology Innovation Program for collaboration with some of our illustrative collaboration on C2 antibody ARGX 117 for MMN and Musk agonist antibody ARGX-119.

Monday Muscle Seminar M&Ms: David Schaffer

Date: 23 May 2022
Time: 15 h 30 min - 16 h 30 min
Location: Visioconference
Monday Muscle Seminar - M&M's
David Schaffer
David Schaffer
Zoom link => https://us02web.zoom.us/j/81380105352 

Directed Evolution of Novel Adeno-Associated Viruses for Clinical Gene Therapy

David Schaffer

Hubbard Howe Jr. Distinguished Professor
Chemical and Biomolecular Engineering, Bioengineering, Molecular and Cell Biology, and the Helen Wills Neuroscience Institute
University of California at Berkeley

Director
QB3 – California Institute for Quantitative Biosciences, Berkeley

 

 

Short Biography

David Schaffer is the Hubbard Howe Professor of Chemical and Biomolecular Engineering, Bioengineering, and Molecular and Cell Biology at the University of California, Berkeley, where he also serves as the Director of the California Institute for Quantitative Biosciences (QB3-Berkeley). He received a B.S. from Stanford University in 1993 and a Ph.D. from MIT in 1998, both in chemical engineering. He then conducted a postdoctoral fellowship at the Salk Institute for Biological Studies before joining Berkeley in 1999. There, he applies engineering principles to optimize gene and stem cell therapies, work that includes developing the concept of applying directed evolution to engineer targeted and efficient viral gene therapy vectors as well as new technologies to investigate and control stem cell fate decisions. He has published >230 papers, has advised >90 graduate students and postdoctoral fellows, is an inventor on >50 patents, and developed technologies that are being used in 9 human clinical trials. In addition, he has co-founded six companies, including a clinical stage, public company (4D Molecular Therapeutics) and a company acquired by Pfizer. Finally, has received recognitions including the National Academy of Inventors, Andreas Acrivos Professional Progress Award, the American Institute of Chemical Engineers Pharmaceutical and Bioengineering Award, the American Chemical Society Marvin Johnson Award, and the Biomedical Engineering Society Rita Shaffer Young Investigator Award.

Monday Muscle Seminar M&Ms: Shahragim Tajbakhsh

Date: 16 May 2022
Time: 12 h 00 min - 13 h 00 min
Location: Visioconference
Monday Muscle Seminar - M&M's
Shahragim Tajbakhsh
Shahragim Tajbakhsh

You cannot copy content of this page

Share This